Astrazeneca Plc stock is traded at $189.01, with a volume of 4,472,286. It is up +2.79% in the last 24 hours and up +20.47% over the past month. A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Previous Close:
$183.88
Open:
$188.44
24h Volume:
4,472,286
Relative Volume:
1.29
Market Cap:
$293.14B
Revenue:
$60.48B
Net Income/Loss:
$10.40B
P/E Ratio:
56.76
EPS:
$3.33
Net Cash Flow:
$8.05B
1W Performance:
+11.50%
1M Performance:
+20.47%
6M Performance:
+3.03%
1Y Performance:
+15.21%
1-Day Range:
$187.11$189.66
1-Week Range:
$182.93$189.66
52-Week Range:
$153.41$212.71
Astrazeneca Plc Stock (AZN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS